www.jezebel.com
Congrats to RFK Jr., As the U.S. Is Poised to Lose Its Measles Elimination Status After 25 Years
After a quarter century where measles was considered eliminated in the U.S., 2025's continuous outbreaks have us back at ground zero.
#disease is an active hashtag on Bluesky. In the last 30 days, 114 people shared 623 posts with it — around 21 a day. Activity is up 17% versus the previous week, peaking on Sep 15 with 45 posts.
Tags most often used together with #disease.
www.jezebel.com
Congrats to RFK Jr., As the U.S. Is Poised to Lose Its Measles Elimination Status After 25 Years
After a quarter century where measles was considered eliminated in the U.S., 2025's continuous outbreaks have us back at ground zero.
www.jezebel.com
There Have Already Been More 2026 Measles Cases in the U.S. Than 2023 and 2024 Combined
In the first three weeks of 2026, there have already been more than 400 new measles cases, as the U.S. looks to blow past 2025's highs.
media.tenor.com
garfield is laying in a box with the words `` nap time '' .
ALT: garfield is laying in a box with the words `` nap time '' .
www.news-medical.net
Galimedix establishes Scientific Advisory Board for Alzheimer's disease to guide development of novel oral drug candidate, GAL-101
Galimedix Therapeutics, Inc., a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious brain and eye diseases, today announced the establishment of a dedicated Alzheimer's Disease Scientific Advisory Board (SAB). The SAB brings together leading global experts with complementary expertise across Alzheimer’s disease biology, biomarkers, cognitive assessment, neurophysiology, genetics, data science and neurological drug development and will provide scientific and clinical guidance as Galimedix advances its Alzheimer’s disease program through clinical development. SAB members include: Andreas Busjahn, PhD, Founder and Managing Director of HealthTwiSt, Berlin, is a biostatistics and data-science expert with broad experience in biomedical research. Willem de Haan, MD, PhD, Neurologist and Senior Researcher at Alzheimer Center Amsterdam, Amsterdam UMC, specializes in neuronal network dysfunction in Alzheimer’s disease and EEG-based measures of brain connectivity and treatment effects. John E. Harrison, PhD, Professor at King’s College London and at Amsterdam UMC, is Chair of the Scientific Advisory Board of Scottish Brain Sciences and Clinical Vice President at Signant Health, with long-standing expertise in cognitive assessment in dementia. Charlotte Teunissen, PhD, Professor of Neurochemistry at Amsterdam UMC, is a leading expert in fluid biomarkers for neurological diseases and...
www.news-medical.net
Roundworm study uncovers cellular effects of kidney disease mutation
A microscopic worm that has no kidneys is helping Rutgers scientists understand a genetic change suspected of causing a serious inherited kidney disease. By making a precise change in the roundworm's DNA and following the proteins it produces, researchers discovered the altered protein failed to reach the place where it normally works. But when a healthy version was present in the same animal, that protein continued doing its job. The findings, published in the journal Genetics, offer clues about how this particular mutation affects cells, the researchers said. They also demonstrate a way to investigate a rising challenge in medicine: understanding what the DNA changes revealed by genetic testing actually mean. As genetic testing becomes more common in medicine, doctors are finding many DNA changes whose effects are difficult to understand. Studying these changes in the tiny roundworm C. elegans can provide answers more quickly and efficiently." Juan Wang, associate research professor, Department of Genetics in the Rutgers School of Arts and Sciences and study's lead author The approach could be applied to other genetic changes affecting protein features that worms and humans share. "Over time, it could help doctors interpret genetic test results more accurately and help researchers understand...
theconversation.com
A new saliva test for endometriosis is in trials. What this and other new endo tests mean for you
Could new tests shorten the long road to an endometriosis diagnosis? The promise is compelling, but the evidence is not there yet.
www.news-medical.net
Maldives meets UN target for reducing premature chronic disease deaths
The Maldives has become the only country in the World Health Organization's South East Asia region to meet the UN target for reducing premature deaths from non-communicable diseases (NCDs), such as cardiovascular and chronic respiratory diseases, cancers and diabetes. Globally, NCDs account for roughly three quarters of all deaths, with millions of people dying prematurely before the age of 70, according to the Some SIDS, especially in the Pacific and Caribbean regions, have among the highest rates of obesity and NCDs in the world because of increasingly sedentary lifestyles and consumption of imported processed foods. Many are far from meeting the United Nations' Sustainable Development Goal (SDG) target of reducing premature deaths from the four key NCDs by one-third among people aged 30 to 70 by 2030. For the Maldives, in the Indian Ocean, a digital-focused primary health care model has played a key part in achieving this goal four years early, according to the WHO. The WHO-supported model was first piloted out on Faafu Atoll, a tiny atoll comprising 23 islands and islets, only five of which are inhabited. 5G internet connectivity Shuaib Ismail, community health coordinator at Faafu Atoll Hospital, run by the Maldives Ministry of Health, Family...
www.technologynetworks.com
Four to Six Daily Servings of Wholegrain Lowers Risk Factors for Heart Disease
Eating four to six servings of wholegrain each day reduces several major risk factors for cardiovascular disease, according to a new study published in the European Heart Journal. The study is a systematic review and meta-analysis, meaning it brings together the results of all existing research in this area. It includes data from 87 clinical trials that tested the effects of eating wholegrain food on risk factors for cardiovascular disease. It shows that eating a diet rich in wholegrain food is likely to prevent heart disease by reducing body weight, blood pressure and the levels of cholesterol and glucose in the blood. The research was led by Dr Helda Tutunchi from Tabriz University of Medical Sciences, Iran. She said: “Although higher wholegrain intake has long been linked to better heart health in population studies, clinical trials have produced mixed findings. This left an important practical question unanswered: how much whole grain should people eat to meaningfully improve cardiovascular health? To address this, we systematically combined and analysed all available randomised controlled trials to identify the amount of whole grain associated with the greatest benefits.” The analysis included more than 6,500 people from trials conducted across Asia, Europe, the United States,...
www.biospace.com
C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer's Day, Joins Cambridge Cognition and The Alzheimer's Trust to Improve Alzheimer's Disease Diagnosis
LONDON--(BUSINESS WIRE)--#Alzheimers--C2N Diagnostics, LLC ("C2N"), a pioneer in advanced diagnostic testing for brain health, and Cambridge Cognition, the neuroscience technology company, announce on World Alzheimer’s Day a partnership with The Alzheimer's Trust, a newly formed subsidiary of The Cancer Screening Trust, to address the urgent and growing burden of Alzheimer's disease and related dementias in the United Kingdom (UK). The collaboration creates an integrated, scalable pathway for earlier and more accurate diagnosis of Alzheimer's disease and related dementias in the UK and includes: C2N's UK Medicines and Healthcare products Regulatory Agency-registered PrecivityAD2® test, which helps health care professionals identify patients with amyloid pathology associated with Alzheimer’s disease; CANTAB Pathway™, Cambridge Cognition's validated digital touchscreen cognitive assessment platform; and The Alzheimer's Trust’s national phlebotomy and MRI imaging infrastructure. UK-based health care professionals can now order the PrecivityAD2® test and the CANTAB Pathway™ through The Alzheimer’s Trust. This combined effort aims to aid in the assessment of individuals presenting with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline. Health care professionals can [email protected] or call UK +44 (0)1935 712430 for ordering information. How PrecivityAD2® Blood Test and CANTAB Pathway™ Can Increase Diagnostic Accuracy The...
www.morningstar.com
Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics
Study published in JAMA Network Open of over 193,000 patients nationwide reveals that individuals with evidence of exposure to Borrelia burgdorferi, the bacterium that causes Lyme disease, are more than four times as likely to have antibodies against other tick-borne pathogens compared to those without. SECAUCUS, N.J., Sept. 21, 2026 /PRNewswire/ -- Nearly one in three patients found to have antibodies against the bacterium that causes Lyme disease also had antibodies against one or more additional tick-borne pathogens, according to a new study by researchers from Quest Diagnostics (NYSE: DGX) and the University of North Carolina at Chapel Hill. Published in JAMA Network Open, the study, titled "Coseropositivity to Tick-Borne Pathogens Among Patients Suspected to Have Lyme Disease," analyzed de-identified test results from 193,260 individuals across the United States who underwent testing for tick-borne diseases between January 2021 and December 2025. The study is believed to be the largest serology-based, simultaneous evaluation of multiple tick-borne pathogens in the U.S. and the largest involving a dataset as recent as 2025. The researchers found that 29.5% of individuals who had antibodies against Borrelia burgdorferi, the bacterium that causes Lyme disease, also had antibodies against at least one other tick-borne pathogen. By comparison,...
Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.